MACK

Merrimack Pharmaceuticals, Inc.
MACK

Overview Fund Activity
Delisted

MACK was delisted on the 17th of May, 2024.

Back to rankings

121 hedge funds and large institutions have $407M invested in Merrimack Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 31 increasing their positions, 36 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
121
Holders Change
+19
Holders Change %
+18.63%
% of All Funds
3.48%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
34
Increased
31
Reduced
36
Closed
15
Calls
$7.79M
Puts
$5.19M
Net Calls
+$2.6M
Net Calls Change
-$2.21M

Top Buyers

1
Millennium Management
Millennium Management
New York
$15M
2
Deutsche Bank
Deutsche Bank
Germany
$17.8M
3
Renaissance Technologies
Renaissance Technologies
New York
$4.15M
4
BFA
BlackRock Fund Advisors
California
$30.6M
5
Goldman Sachs
Goldman Sachs
New York
$4.8M

Top Sellers

1
State Street
State Street
Massachusetts
$24.8M
2
Jennison Associates
Jennison Associates
New York
$35.3M
3
DCM
DAFNA Capital Management
California
$0
4
CCA
Catalyst Capital Advisors
New York
$217K
5
Morgan Stanley
Morgan Stanley
New York
$3.67M
Name Holding Trade Value Shares
Change 		Shares
Change %
GE
126
General Electric
Ohio
– -$222K -5,610 Closed
Jane Street
127
Jane Street
New York
– -$178K -4,498 Closed
SCM
128
Stevens Capital Management
Pennsylvania
– -$127K -3,215 Closed
ST
129
Spot Trading
Illinois
– -$95K -2,405 Closed
VKH
130
Virtu KCG Holdings
New York
– -$79K -1,983 Closed
PPA
131
Parametric Portfolio Associates
Washington
– -$73K -1,837 Closed
SB
132
Suntrust Banks
Georgia
– -$70K -1,790 Closed
SG Americas Securities
133
SG Americas Securities
New York
– -$67K -1,694 Closed
WAM
134
Wolverine Asset Management
Illinois
– -$21K -534 Closed
TRCT
135
Tower Research Capital (TRC)
New York
– -$9K -236 Closed
2 3 4 5
6